Jeffrey Lim

Co-founder & CTO, ImmunoQs | Singapore

Professional Overview
Jeffrey Lim is a seasoned technology leader and co-founder with a proven track record of driving innovation and business growth. As the Co-founder and Chief Technology Officer of ImmunoQs, he leverages his extensive expertise in biotechnology and software development to spearhead the company's technological strategy and product development efforts.

Experience Summary

Current Role
As the Co-founder and CTO of ImmunoQs, a Singapore-based biotechnology startup, Jeffrey is responsible for leading the company's technological vision and roadmap. He oversees the design, development, and implementation of the company's cutting-edge immunotherapy platform, which has the potential to revolutionize personalized cancer treatment. Under his technical leadership, ImmunoQs has secured several high-profile partnerships and is poised to make a significant impact in the field of precision medicine.

Career Progression
Prior to co-founding ImmunoQs, Jeffrey held various research and technical roles in the healthcare and biotechnology sectors. As a Senior Research Officer II at ASTAR, he conducted groundbreaking research in the areas of immunology and bioinformatics, contributing to the development of novel diagnostic and therapeutic solutions. He also gained valuable experience as a Product Specialist at Roche, where he provided technical support and training to healthcare professionals on the company's innovative medical devices.

Jeffrey's career journey also includes roles as a Research Officer at Singapore General Hospital and a Medical Technologist, where he honed his skills in laboratory procedures, data analysis, and project management.

Academic Background
Jeffrey holds a Bachelor of Science degree in Molecular Biology and Biotechnology from the National University of Singapore, where he graduated with distinction. During his studies, he participated in several research internships, including a stint at the UQ Institute for Molecular Bioscience, further solidifying his passion for scientific discovery and innovation.

Areas of Expertise

• Biotechnology and immunology

• Software development and engineering

• Data analysis and bioinformatics

• Product management and technical sales

• Cross-functional team leadership and collaboration

Professional Impact
Throughout his career, Jeffrey has made significant contributions to the advancement of healthcare and biotechnology. His research at ASTAR led to the development of novel diagnostic tools and therapeutic strategies, which have the potential to improve patient outcomes. As a Co-founder and CTO of ImmunoQs, he has spearheaded the company's efforts to create a groundbreaking immunotherapy platform that has attracted the attention of industry leaders and investors.

Conclusion
With his extensive expertise, strong technical background, and entrepreneurial spirit, Jeffrey Lim is poised to continue driving innovation and making a lasting impact in the biotechnology industry. As he leads ImmunoQs through its next phase of growth, he remains committed to leveraging the power of technology and scientific research to transform the way personalized cancer treatments are delivered.